The Medical Cannabis Research Center is launching the following studies on cannabis use in 2021.
A Registry Study of Medical Cannabis Patients in Pennsylvania
This patient registry study will recruit medical cannabis patients from 12 dispensaries owned and operated by Verano.
The study will recruit up to 1,200 patients across all 12 sites (approximately 110 patients per site). Participants will complete a baseline quantitative interview, a quantitative follow-up interview every 90 days, and a subsample will complete a qualitative interview.
The patient registry study has four specific aims:
- Describe the socio-demographic characteristics of patients enrolled in the medical cannabis program at Zen Leaf dispensaries
- Describe the medical histories of medical cannabis patients enrolled at Zen Leaf dispensaries, including the specific qualifying condition(s) for medical cannabis
- Describe the cannabis-using practices of medical cannabis patients enrolled at Zen Leaf dispensaries, including cannabis strains, forms, and modes of administration as well as other drug use
- Describe the effects of medical cannabis use on serious medical conditions, e.g., pain, opioid dependence, and related symptoms overtime among medical cannabis patients enrolled at Zen Leaf dispensaries
This study began enrollment in June 2021.
The Clinical Research Core will provide the personnel and administrative support to conduct clinical trials and other clinical research activities related to medical cannabis.
It will leverage Drexel’s clinical expertise and the availability of patients with qualifying conditions for medical cannabis such as, but not limited to, HIV, neuropathies, and PTSD.
The clinical core will launch in early 2022.